Veerle Van De Velde, MD

Veerle Van De Velde, MD

Veerle Van De Velde, MD, currently works as a Global Project physician in the IGM therapeutic area (TA). In this role, she is responsible for overseeing global trials, mostly in rare respiratory indications. Tasks include protocol development and feedback, team training, site communication, data review and interpretation, DMC and adjudication support, data review meetings, assistance with CSR writing. Drawing on more than 25 years of experience in the pharmaceutical and CRO industry, Dr. Van De Velde gets involved in business development activities and may also act in a consultant role as part of a molecular development team.

Dr. Veerle Van De Velde obtained her medical degree in 1995 and worked as a sub-investigator in the Respiratory Department of the University Hospital in Ghent. She started her career in drug Development in the respiratory area in a hospital setting and spent four years doing clinical research in Phase II, III, and IV trials in asthma, COPD, respiratory infections and pulmonary oncology under the guidance of Prof R.A. Pauwels. As a sub-I, Dr. Van De Velde was responsible for recruiting patients, administering patients' project-specific procedures, compiling CRF data, collecting adverse event information, and timely reporting to sponsors and ethics committees. She has experience in both basic and clinical research, with expertise in rare respiratory disease and IPF. Later, she worked as a project physician in a variety of indications and was responsible for overseeing global clinical trials, medical data review and team training both internally and externally.